CLINICAL_TRIALS
trial_result
· 2018-10-17
Clinical Trial Update: Pilot Study of Velcade® in IgA Nephropathy [Phase 4]
Summary
Pilot Phase 4 study of Velcade in IgA nephropathy has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Rogosin Institute | Conditions: Chronic Kidney Disease, IgA Nephropathy | Phase 4 | Status: COMPLETED | Results posted: 2018-10-17